Nomura Holdings’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Nomura Holdings’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-31,500	Closed	-$2.93M	–	2658
2021 Q4	$2.93M	Buy	+31,500	New	+$2.08M	0.01%	878

Nomura Holdings's ARNA Position: Q1 2022 in Review

Nomura Holdings sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 56,564 shares — an estimated $5.26M sold.

Nomura Holdings first reported a position in ARNA in Q2 2013 and held it in 10 quarters. The position peaked at $5.26M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Nomura Holdings reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Nomura Holdings sold 56,564 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $5.26M.
Nomura Holdings first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
Nomura Holdings's Arena Pharmaceuticals Inc position peaked at $5.26M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Nomura Holdings's 13F filing for Q1 2022, filed 18 May 2022.